Baltimore, Md. (July 11, 2024) – Jhpiego has once again been recognized as a “Very High Performer” and a “Consistently Strong Performer” by Global Health 50/50 (GH5050) for its continued efforts to prioritize gender equality—both within the organization and in the global health sector broadly. Last year, Jhpiego was recognized as a “Very High Performer”
Exciting news! The Jhpiego-led, Unitaid-funded AMPLI-PPHI (Accelerating Measurable Progress and Leveraging Investments for Postpartum Hemorrhage Impact) project has reached tens of thousands of women with critical drugs to prevent and treat postpartum hemorrhage, a leading cause of maternal deaths worldwide. The project, operating now in four countries — Democratic Republic of Congo, Guinea, India, and Kenya
Geneva/Baltimore, 9 July 2024 – Three critical drugs for preventing and treating postpartum hemorrhage – the leading cause of death in childbirth – have reached women in the Democratic Republic of Congo, Guinea, India and Kenya through a Unitaid-funded, Jhpiego-led program. Postpartum hemorrhage, which is defined as a severe loss of blood after giving birth,
